Resistance mutation info of drug
Drug General Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug ID | D08ANZ | |||||||||||||||
Drug Name | Pembrolizumab | |||||||||||||||
Drug Type | Monoclonal antibody | |||||||||||||||
Company | Merck Kenilworth, NJ | |||||||||||||||
Drug Resistance Mutations | ||||||||||||||||
Target Name | GTPase Nras (NRAS) | Target Info | ||||||||||||||
Gene Name | NRAS | |||||||||||||||
Uniprot ID | RASN_HUMAN | |||||||||||||||
Species | Homo sapiens | |||||||||||||||
Reference Sequence |
MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAG QEEYSAMRDQYMRTGEGFLCVFAINNSKSFADINLYREQIKRVKDSDDVPMVLVGNKCDL PTRTVDTKQAHELAKSYGIPFIETSAKTRQGVEDAFYTLVREIRQYRMKKLNSSDDGTQG CMGLPCVVM [Homo sapiens] |
|||||||||||||||
Targeted Disease | Skin cancer | |||||||||||||||
Drug Resistance Mutations |
|
|||||||||||||||
References | ||||||||||||||||
REF 1 | Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma. Oncotarget. 2015 Dec 8;6(39):42008-18. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.